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Abstract
Peritoneal dialysis (PD) is a highly effective therapeutic method employed to remove toxic byproducts and 
metabolites from the body when this role can no longer be fulϐilled by the kidneys that are either permanently 
damaged as in chronic kidney failure, or need time and proper treatment to recover from other diseases of the 
kidney itself or pathologies that may affect the renal function as they progress. This technique uses the peritoneum 
ability to act as a ϐiltering membrane, through which the toxins, such as urea and creatinine, pass into the peritoneal 
cavity, being subsequently removed along with the dialysate.
The study describes the evolution and follows the dynamic of the biomarkers in 5 dogs suffering from kidney 
failure, that did not respond well to speciϐic treatment and for whom peritoneal dialysis was the best therapeutic 
approach.
Peritoneal dialysis was performed in 5 dogs, with ages between 5 and 15 years old, during 6 months, using 
Diaenal PD4 glucose 1.36% W/V/13.6mg/ml produced by Baxter. Blood samples were taken from each dog 
before the procedure, and then twice a week to monitor the electrolytes, creatinine and urea levels. Also, before 
introducing the dialysate into the peritoneal cavity, the patients underwent ultrasound examination to evaluate 
the kidneys and to exclude other problems that would prevent this maneuver, and 2 hours after administering the 
dialysate to measure the absorption rate.
All 5 patients exhibited an important recovery after 8-14 dialysis sessions, showing that the procedure was 
able to maintain kidney stability, a fact proved also by the levels of metabolites involved in the clinical evolution. 
Ecography performed before and after dialysis revealed that the hydration level is key point in the success of the 
procedure.
Peritoneal dialysis is a more affordable and less invasive procedure to gradually eliminate the uremic toxins. It 
can offer temporary support for kidneys until the recovery of renal function is done, or when hemodialysis cannot 
be used as a basic treatment.
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INTRODUCTION
Peritoneal dialysis (PD) is a highly effective 
therapeutic method employed to remove toxic 
byproducts and metabolites from the body when 
this role can no longer be fulϐilled by the kidneys 
that are either permanently damaged as in chronic 
kidney failure, or need time and proper treatment 
to recover from other diseases of the kidney itself 
or pathologies that may affect the renal function as 
they progress. This technique uses the peritoneum 
ability to act as a ϐiltering membrane, through 
which the toxins, such as urea and creatinine, 
pass into the peritoneal cavity, being subsequently 
removed along with the dialysate. (Bloom and 
Labato, 2011)
MATERIALS AND METHODS
The research has been carried out in the Clinic 
of The Faculty of Veterinary Medicine Bucharest in 
2014, during six months. Peritoneal dialysis was 
performed in 5 dogs, with ages between 5 and 
15 years old, using Diaenal PD4 glucose 1.36% 
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W/V/13.6mg/ml produced by Baxter. A 4.5% 
solution should only be used when patients are 
ϐluid overloaded, and a 1.25% solution is generally 
adequate in normovolemic patients. (Mathews, 
2006).
Standard commercial dialysate solutions are 
designed to remove urea, creatinine, potassium 
and phosphate from the plasma into the dialysate 
by the process of diffusion. A variety of dialysate 
solutions can be used with differing osmolalities 
on a case by case basis depending on the ϐluid 
balance of the patient. Fluid and solutes move 
across the peritoneum by diffusion, ultraϐiltration 
and convection. Urea and potassium diffuse 
across the peritoneal membrane quickly, whereas 
creatinine and phosphorus take longer to 
equilibrate (Zabetakis et al., 1993).
The major indication for peritoneal dialysis 
is renal failure with oliguria or anuria. It may 
be indicated if the blood urea nitrogen (BUN) 
concentration is  greater than 100 mg/dL (35 
mmol/L) or the serum creatinine concentration is 
greater than 10 mg/dL (884 umol/L) and medical 
management has failed to elicit a positive response 
(Lew et al., 2005).
Before introducing the dialysate into the 
peritoneal cavity, the patients underwent 
ultrasound examination to evaluate the kidneys 
and to exclude other problems that would prevent 
this maneuver and 2 hours after administering the 
dialysate to measure the absorption rate.
A catheter was placed using strict aseptic 
technique with mild sedation and local anesthesia, 
because these animals with acute renal failure 
were generally depressed. The catheter can enter 
the abdomen on midline or via a paramedian 
approach, at the level of the umbilicus. The 
catheter was directed caudally and positioned in 
the lower pelvis. Catheter placement should be 
veriϐied by infusing, and easily retrieving, a small 
volume of dialysate (2-5 ml) before the catheter is 
secured. (Cowgill, 1995, Ash, 2003).
Patient parameters were monitored daily, 
including: perfusion and hydration (PCV/
TP), blood pressure, heart rate, urine output, 
temperature, CVP; respiration (respiratory 
distress can occur from over distention of the 
abdomen or leakage of dialysate into the pleural 
cavity).
Three of the ϐive dogs were diagnosed with 
chronic renal failure and two of them with acute 
renal failure. The amount of dialysate solutions 
used in this study is 1 liter for each 1m3 body 
surface. The dialysate was maintained into the 
peritoneum for four hours in each case and then 
it was drained out by gravitation throurgh the 
catheter.
All ϐive dogs were treated with IV ϐluids and 
antibiotics prior to peritoneal dialysis. Median age 
presentation was 8 years (range 3–15 years). At 
the start of peritoneal dialysis median BUN was 
160 mg/dl (range 97–230) and median creatinine 
was 11,68 mg/dl (range 10,9–13,8), (Table 1).
Peritoneal dialysis was conducted at every 
two days in all cases and blood samples were 
taken from each twice a week to monitor the 
electrolytes, creatinine and urea levels.
RESULTS AND DISCUSSION
All 5 patients exhibited an important recovery 
after 8-14 dialysis sessions, showing that the 
procedure was able to maintain kidney stability, 
a fact proved also by the levels of metabolites 
involved in the clinical evolution.
Ecography performed before and after dialysis 
revealed that the hydration level is key point in the 
success of the procedure.
VIŢĂLARU et al
Tab. 1. Peritoneal dialysis patient’s data
Case 
number
Patient 
name
Gender Weight Breed
Age 
(years)
Diagnosis
Dianeal PD4
(ml)
1 JESSE Female 5,1 Crossbreed 15 Chronic renal failure 165
2 PUFFY Male 5,7 Pekingese 10 Chronic renal failure 175
3 BILLY Male 4,7 Crossbreed 7,5 Chronic renal failure 155
4 ALMA Female 8
Yorkshire 
Terrier
3 Acute renal failure 270
5 BLAK Male 7,5
Bichon 
Maltese
5 Acute renal failure 265
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The amount of peritoneal ϐluid drained from 
the patient’s peritoneum is proportional with the 
effect of the dialysis and it depends on the patient’s 
hydration level. In all ϐive cases, the amount of 
peritoneal ϐluid collected after four hours by 
gravitation throurgh the catheter was bigger than 
the amount of the dialysate introduced into the 
peritoneal cavity.
All ϐive dogs were medically stable at the end 
of the procedure. Median duration of peritoneal 
dialysis was 20 days (range 16–29 days) and the 
median number of the dialyze session was 9,6 
(8-13 sessions). Azotemia decreased in all dogs 
during peritoneal dialysis. At the end of peritoneal 
dialysis median BUN was 36,8 mg/dl (range 25–
44) and median creatinine was 2,46 mg/dl (range 
2,0–3,1 mg/dl), (Table 2).
One of the most common complications is 
infection at the catheter insertion site. We have 
encountered no case of peritonitis, although in the 
literature (Bhatt, 2011) are cited frequent cases.
Our results are comparable to those obtained 
in the literature (Bhatt, 2011, Cowgill, 1995), the 
treatment duration was shorter in acute cases and 
longer in the chronic ones .
We have recorded all patient’s data and all 
the results were inserted into charts to be able 
to follow the descending trend of the urea and 
creatinine (Fig. 1, 2).
CONCLUSION
The average duration of peritoneal dialysis 
was 20 days (range 16–29 days) and the average 
number of the dialyze session was 9,6 (8-13 
sessions).
At the end of peritoneal dialysis median 
BUN was 36,8 mg/dl (range 25–44) and median 
creatinine was 2,46 mg/dl (range 2,0–3,1 mg/dl).
Peritoneal dialysis is a more affordable and 
less invasive procedure to gradually eliminate 
the uremic toxins in management of acute kidney 
injury refractory to ϐluid therapy. It can offer 
temporary support for kidneys until the recovery 
of renal function is done, or when hemodialysis 
cannot be used as a basic treatment.
Tab. 2. The initial and ϐinal BUN and creatinine values of the patients submitted to peritoneal dialysis
Case 
number
Patient 
name
Initial BUN 
(mg/dL)
Initial 
Creatinine 
(mg/dL)
Final BUN 
(mg/dL)
Final 
Creatinine 
(mg/dL)
PD 
duration
(days)
Dialyze 
session
1 JESSE 174 13,8 44 3.1 29 13
2 PUFFY 230 11,0 42 2,9 20 10
3 BILLY 147 10,9 35 2,3 18 9
4 ALMA 153 11,1 38 2,0 16 8
5 BLAK 97 11,6 25 2,0 16 8
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Fig. 1. Evolution of the patient’s urea following dialysis 
treatment.
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Fig. 2. Evolution of the patient’s creatinine following 
dialysis treatment.
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